Latest Us Market News

Acusensus Limited has raised its FY26 revenue guidance to $83-$87 million, driven by significant new contracts in the US and New Zealand and expansions in Australia. This upgrade signals strong momentum in the company’s AI-powered road safety enforcement business.

Decidr AI Industries has announced a strategic acquisition of Delaware-based Sugarwork Inc., marking its official entry into the US market and enhancing its Agentic AI platform with advanced knowledge transfer capabilities.

Cyclopharm Limited reaffirms its ambitious target of 250–300 US Technegas installations by late 2026, driven by FDA approval, CMS reimbursement, and a growing pipeline of healthcare sites. The company reports record half-year revenue growth, signaling strong momentum in the expanding lung imaging market.

Nuix Limited’s 2025 AGM revealed steady ACV growth, a leadership transition, and a strategic push centered on its Nuix Neo platform to fuel future expansion.

AML3D has secured a significant $1.7 million order for its ARCEMY X large-scale metal 3D printer from US defense supplier FasTech, marking a key milestone in its US expansion strategy.

Serko Limited reports a robust 45% increase in total income for the first half of FY26, driven by its GetThere acquisition and strong momentum in Booking.com for Business, alongside a significant uplift in EBITDAFI.

Airtasker has expanded its US partnership with iHeartMedia, securing an additional US$5 million in media resources and a A$10 million equity investment to accelerate its growth in the American market.

Airtasker has raised $10 million in a strategic equity placement led by iHeartMedia, aiming to accelerate its growth in the US and UK markets through targeted marketing and expanded media partnerships.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Iondrive Limited’s Phase 1 techno-economic evaluation of its IONSolv™ modular rare earth elements recycling plant reveals promising financial metrics and a scalable US rollout strategy. Phase 2 validation is underway to refine assumptions and advance commercial deployment.

Genetic Signatures Limited unveiled a year of strategic transformation and robust financial growth at its 2025 AGM, highlighting leadership renewal and a sharpened commercial focus. The company’s FY25 revenue jumped 66%, driven by strong product demand and expanded market presence.

Red Mountain Mining has secured approval to list on the US OTCQB market, with trading set to begin on November 17, 2025. The move enhances liquidity and positions the company to leverage US government funding for its critical minerals projects.